You searched for "regulation"

3508 results found

SightCare Awards shortlist announced

SightCare, the UK’s leading provider of business and networking services to independent optometrists and opticians, is excited to announce the shortlisted entries to our prestigious awards, celebrating excellence in the independent optical sector. Now in their fifth successful year, the...

SpaMedica eyes innovation, unveiling UK first-of-its-kind vision care centre in Hereford

New relocatable Ophthalmic Diagnostic and Treatment Centre will deliver comprehensive eyecare directly into local communities. In a commitment to revolutionise community healthcare, a first-of-its-kind eye health centre has been launched in Hereford by SpaMedica, designed specifically to deliver high-quality eyecare...

100 years of insulin

*Joint first authors The centenary of the discovery of insulin is a time to celebrate one of the most significant scientific discoveries of the 20th century. Background Before 1923, Type 1 diabetes mellitus [T1DM] resulted in death from severe ketoacidosis...

New research shows the unhealthy state of access to medicine and medical devices for blind patients

Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

SLT versus medication for OAG

This paper appraised existing randomised clinical trials (RCTs), which compared selective laser tabeculoplasty (SLT) with medical therapy for open-angle glaucoma (OAG), and performed a systematic review and meta-analysis. A total of 1229 patients in eight trials were included from PubMed,...

Teprotumumab for chronic TED

This retrospective case series looks at the use of teprotumumab in nine patients with thyroid eye disease (TED) of clinical activity score ≤one and >nine months duration, in an American cohort. Current European guidelines have suggested the use of teprotumumab...

What to expect when meeting a statistician

There are a growing number of statisticians working closely with ophthalmologists. They have different training but they are driven by the same goal: to perform high quality evidence based clinical research [1,2]. In a perfect world we would simply conduct...

Ambient scribes: The silent revolution

Clinical practice is in the midst of a profound digital transformation with a new wave of technology gaining increasing prominence: ambient scribes. These AI-powered tools streamline documentation by converting doctor–patient conversations into structured clinical notes in near real time. Healthcare...

The risk factors associated with isolated microvascular third nerve palsy

The authors used the Rochester Epidemiology Project for this retrospective case review of third nerve palsy. Inclusion criteria was adults >18 years, with new onset isolated microvascular third nerve palsy diagnosed within a 36-month period, with recovery or significant improvement,...

GA position of eyes

The authors assessed eye position based on the corneal reflex position (Hirschberg test) using a standardised measurement on pictures taken at the preoperative evaluation and under general anaesthesia (GA) in 41 patients. The mean ocular deviation taken at the preoperative...

Pegcetacoplan: A breakthrough treatment for dry age-related macular degeneration?

Age-related macular degeneration (AMD) is a degenerative condition affecting the macula, the part of the retina responsible for central vision. It is characterised by the presence of drusen and retinal pigment epithelium (RPE) abnormalities in the absence of other macular...

Aflibercept treatment in polypoidal choroidal vasculopathy

The authors present a study to evaluate the anatomical and functional efficacy of aflibercept intravitreal (IVT) as a monotherapy in polypoidal choroidal vasculopathy (PCV) in a Caucasian population treated with initial three-monthly aflibercept IVT, followed by a bimonthly regimen for...